The COVID-19 in athletes (COVA) study: a national study on cardio-pulmonary involvement of SARS-CoV-2 infection among elite athletes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 2,71 MB, PDF-dokument
COVID-19 can cause cardiopulmonary involvement. Physical activity and cardiac complications can worsen prognosis, while pulmonary complications can reduce performance.
Aims
To determine the prevalence and clinical implications of SARS-CoV-2 cardiopulmonary involvement in elite athletes.
Methods
An observational study between 1 July 2020 and 30 June 2021 with the assessment of coronary biomarkers, electrocardiogram, echocardiography, Holter-monitoring, spirometry, and chest X-ray in Danish elite athletes showed that PCR-tested positive for SARS-CoV-2. The cohort consisted of male football players screened weekly (cohort I) and elite athletes on an international level only tested if they had symptoms, were near-contact, or participated in international competitions (cohort II). All athletes were categorized into two groups based on symptoms and duration of COVID-19: Group 1 had no cardiopulmonary symptoms and duration ≤7 days, and; Group 2 had cardiopulmonary symptoms or disease duration >7 days.
Results
In total 121 athletes who tested positive for SARS-CoV-2 were investigated. Cardiac involvement was identified in 2/121 (2%) and pulmonary involvement in 15/121 (12%) participants. In group 1, 87 (72%), no athletes presented with signs of cardiac involvement, and 8 (7%) were diagnosed with radiological COVID-19-related findings or obstructive lung function. In group 2, 34 (28%), two had myocarditis (6%), and 8 (24%) were diagnosed with radiological COVID-19-related findings or obstructive lung function.
Conclusions
These clinically-driven data show no signs of cardiac involvement among athletes who tested positive for SARS-CoV-2 infection without cardiopulmonary symptoms and duration <7 days. Athletes with cardiopulmonary symptoms or prolonged duration of COVID-19 display, exercise-limiting cardiopulmonary involvement.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 2149919 |
Tidsskrift | European Clinical Respiratory Journal |
Vol/bind | 10 |
Udgave nummer | 1 |
Antal sider | 11 |
ISSN | 2001-8525 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
This work was funded by Team Denmark, Novo Nordisk, and the Danish National Football League. Novo Nordisk Foundation. Special thanks to our collaborators, Team Danmark and the Danish National Football League. Study nurse Liselotte Klint Christiansen is thanked for her excellent contribution to the Holter analyses. Medical students, Tino Severinsen and Kristine Lund Michaelsen for fast and efficient data collection. Secretaries Christina Tegner Björnberg Kobelecki, Trine Ridorf-Hansen, and Karen Marie O´Neill for excellent service to ensure all logistics made the study possible.
Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
ID: 366761524